APGE
Ticker
Apogee Therapeutics, Inc.
APGE · Healthcare · Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma,…Apogee Therapeutics, Inc. (APGE), in the Healthcare sector, has 29 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 29 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 5 and filed Aug 8. The most active filer was Michael Thomas Henderson with 11 filings. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
29
0 buys · 29 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$170.6M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 5
Filed Aug 7
ADViAverage daily dollar volume
$371.2M
market data
Share price · 12M
$135 (+137.0%)
Adjusted for splits and dividends.
Volume by month
Buys $991K
Sells $176.4M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
CDRecent filings
Carl DambkowskiSALE
Chief Medical Officer
$738K5,500 sh × $134.17
Exec Aug 5
Filed Aug 7 · 8:00 PM ET Michael Thomas HendersonSALE Chief Executive Officer $2.7M
20,000 sh × $133.63
Exec Jul 8
Filed Jul 10 · 8:00 PM ET Carl DambkowskiSALE Chief Medical Officer $730K
5,500 sh × $132.74
Exec Jul 1
Filed Jul 2 · 8:13 PM ET Michael Thomas HendersonSALE Chief Executive Officer $10.6M
80,000 sh × $132.54
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $3.5M
26,400 sh × $132.60
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.5M
18,306 sh across 4 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $433K
5,500 sh × $78.71
Exec Jun 3
Filed Jun 5 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.6M
20,000 sh across 2 lots
Exec May 13
Filed May 15 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $463K
5,500 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET Jane HendersonSALE Chief Financial Officer $180K
2,000 sh × $90.00
Exec Apr 16
Filed Apr 17 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.6M
19,800 sh across 2 lots
Exec Apr 8
Filed Apr 10 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $458K
5,400 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET Jane HendersonSALE Chief Financial Officer $170K
2,000 sh × $85.00
Exec Mar 25
Filed Mar 27 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.5M
20,000 sh across 3 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $376K
5,300 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.2M
19,045 sh across 2 lots
Exec Feb 11
Filed Feb 13 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $161K
2,481 sh × $64.88
Exec Feb 4
Filed Feb 4 · 5:30 PM ET Peter Evan HarwinSALE Director $133.5M
1,750,000 sh × $76.30
Exec Jan 22
Filed Jan 22 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.6M
19,530 sh across 5 lots
Exec Jan 14
Filed Jan 16 · 5:30 PM ET Carl DambkowskiSALE Chief Medical Officer $1.4M
17,774 sh across 2 lots
Exec Jan 7
Filed Jan 9 · 5:30 PM ET Jane HendersonSALE Chief Financial Officer $609K
8,000 sh across 3 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET Jane HendersonSALE Chief Financial Officer $120K
1,500 sh × $80.00
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $1.5M
19,440 sh across 2 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET Michael Thomas HendersonSALE Chief Executive Officer $3.0M
40,000 sh × $75.01
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET Jane HendersonSALE Chief Financial Officer $112K
1,500 sh × $75.00
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET